MedPath

Comparison of marma therapy and Hridya amrit vati in high blood pressure

Not yet recruiting
Conditions
Essential (primary) hypertension,
Registration Number
CTRI/2020/05/025316
Lead Sponsor
Uttarakhand ayurved University Rishikul campus haridwar
Brief Summary

Globally, hypertension is seen as a leading causes of mortality, as it has role in cardiovascular diseases and stroke . Hypertension is also difficult to manage effectively, as it requires consistent treatment after it is diagnosed, due to lack of awareness and patient compliance. In this study we will see the role of Marma therapy and life style modification in the stage one hypertensive patients . life style modification can be defined as altering the long term  unhealthy habits such as over eating , limited physical  activity etc  . Marma therapy ; it is a therapaeutic  healing through subtle energy points in the body . Hypertension can be  managed by modern medicine but unfortunately accompanied with unwanted adverse effect . so this study is intends to evaluate the effect of marma therapy along with life style modification in stage 1 hypertension.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Subjects will be enrolled with stage 1 hypertension (130-139/80-89) Hypertensive patients who are drug-naive will be enrolled for the study Normal LV function.

Exclusion Criteria

Hypertensive patients with B.P greater or equal to 140 / 90 mmHg LVEF < 50 % CKD , Serum creatinine > 1.7.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
lowering in B.P from 140/90 mmhg to the normal ( Acc to the ACC and AHA )6 months
Secondary Outcome Measures
NameTimeMethod
not anynot any

Trial Locations

Locations (1)

Rishikul Ayurvedic college

🇮🇳

Hardwar, UTTARANCHAL, India

Rishikul Ayurvedic college
🇮🇳Hardwar, UTTARANCHAL, India
Dr S k joshi
Principal investigator
9897523499
mrityunjaymission@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.